showed that FBXW7 inhibits malignant proliferation and migration of cholangiocarcinoma cells and enhances their sensitivity to cisplatin chemotherapy, by modulating NOTCH1 and MCL1 expression. Here, NOTCH1 is linked to cholangiocarcinoma.